The quadrivalent market size is expected to see strong growth in the next few years. It will grow to $12.88 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to global health events, competitive dynamics, educational campaigns, regulatory changes, evolving disease patterns. Major trends in the forecast period include disease prevalence, regulatory environment, healthcare infrastructure, consumer awareness and education, competitive landscape.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report
Segmentation & Regional Insights
The quadrivalent market covered in this report is segmented –
1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray
2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies
3) By Disease: Cancer, Hepatitis, Pneumococcal disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)
North America was the largest region in the quadrivalent market in 2023. The regions covered in the quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9335&type=smp
Major Driver Impacting Market Growth
The rising prevalence of chronic and infectious diseases is expected to propel the growth of the quadrivalent market moving forward. A chronic disease is a long-term sickness caused by genetics and lifestyle, whereas an infectious disease is any ailment caused by an infectious agent such as a virus, bacteria, fungus, or protozoan. Quadrivalent vaccines have a significant impact in preventing morbidity and mortality from serious infections, as well as diseases other than the specific infections they are designed to target. Quadrivalent vaccines are being used to prevent chronic (non-communicable) diseases when infectious agents are involved in carcinogenesis. For instance, in September 2022, according to the World Health Organization, a Switzerland-based agency responsible for international public health, every year, 17 million people die from a chronic or noncommunicable disease (NCD) before the age of 70. Furthermore, in 2021, there were estimated 247 million cases of malaria (an infectious disease) globally, with an estimated 619,000 fatalities. Therefore, the rising prevalence of chronic and infectious diseases is driving the growth of the quadrivalent market.
Key Industry Players
Major companies operating in the quadrivalent market are focusing on innovative products such as narcan to drive revenues in their market. Narcan (naloxone hydrochloride) nasal spray 4 mg is used to assist in reversing opioid overdoses during a spike in overdose deaths. For instance, in December 2021, Sandoz International GmbH, a Germany-based pharmaceutical company launched Narcan. Narcan nasal spray is administered to individuals who have overdosed on opioids such as heroin, fentanyl, morphine, or prescription opioid painkillers. It works by quickly blocking the effects of opioids on the brain and can rapidly restore normal breathing and consciousness in someone who is experiencing an overdose. It is specifically designed to rapidly reverse the effects of an opioid overdose, which can be life-threatening.
The quadrivalent market report table of contents includes:
1. Executive Summary
2. Quadrivalent Market Characteristics
3. Quadrivalent Market Trends And Strategies
4. Quadrivalent Market – Macro Economic Scenario
5. Global Quadrivalent Market Size and Growth
……………….
31. Global Quadrivalent Market Competitive Benchmarking
32. Global Quadrivalent Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Quadrivalent Market
34. Quadrivalent Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
https://goodprnews.com/office-and-factory-buildings-global-market-size/
https://goodprnews.com/online-event-ticketing-global-market-size/
https://goodprnews.com/oxygen-therapy-global-market-size/
https://topprnews.com/office-and-factory-buildings-global-market-share/
https://topprnews.com/online-event-ticketing-global-market-share/
https://topprnews.com/oxygen-therapy-global-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
